Phenylacetylglutamine (NSC 203800) (Synonyms: NSC 203800, PAG, Phenylacetyl L-Gln) |
| カタログ番号GC33462 |
フェニルアセチルグルタミン (NSC 203800) は、アミノ酸発酵による結腸微生物代謝産物です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 28047-15-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Phenylacetylglutamine (NSC203800) is a colic microbial metabolite that comes from amino acid fermentation phenylacetylglutamine is a colic microbial metabolite of amino acid fermentation and it comes from the glutamine binding of phenylacetic acid, phenylacetic acid is almost entirely from the microbial conversion of phenylalanine[1].
Phenylacetylglutamine (NSC203800) might be a potential biomarker for ischemic stroke (IS) and unfavorable functional outcomes in patients with IS[2].
References:
[1]. Poesen R, Claes K, et,al. Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD. J Am Soc Nephrol. 2016 Nov;27(11):3479-3487. doi: 10.1681/ASN.2015121302. Epub 2016 May 26. PMID: 27230658; PMCID: PMC5084895.
[2]. Yu F, Li X, Feng X, Wei M, Luo Y, Zhao T, Xiao B, Xia J. Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke. Front Cardiovasc Med. 2021 Dec 23;8:798765. doi: 10.3389/fcvm.2021.798765. PMID: 35004911; PMCID: PMC8733610.
Average Rating: 5 (Based on Reviews and 18 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *